Species-differences in the in vitro biotransformation of trifluoroethene (HFO-1123).


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
12 2023
Historique:
received: 02 08 2023
accepted: 30 08 2023
medline: 1 11 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: ppublish

Résumé

1,1,2-Trifluoroethene (HFO-1123) is anticipated for use as a refrigerant with low global warming potential. Inhalation studies on HFO-1123 in rats indicated a low potential for toxicity (NOAELs ≥ 20,000 ppm). In contrast, single inhalation exposure of Goettingen

Identifiants

pubmed: 37792044
doi: 10.1007/s00204-023-03603-3
pii: 10.1007/s00204-023-03603-3
pmc: PMC10567879
doi:

Substances chimiques

trifluoroethene Z2866M3Z1A
Acetylcysteine WYQ7N0BPYC
Lyases EC 4.-
Glutathione GAN16C9B8O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3095-3111

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

J Appl Toxicol. 2006 Mar-Apr;26(2):148-61
pubmed: 16252258
Drug Metab Dispos. 2005 Oct;33(10):1429-37
pubmed: 15987776
Adv Pharmacol. 1994;27:115-62
pubmed: 8068551
Toxicol Ind Health. 1994 Jan-Apr;10(1-2):103-12
pubmed: 7570611
Chem Biol Interact. 1998 Nov 6;116(1-2):31-43
pubmed: 9877199
Toxicol Rev. 2006;25(4):213-9
pubmed: 17288493
Arch Toxicol. 2003 Jul;77(7):365-70
pubmed: 12700887
Drug Metab Dispos. 1999 Mar;27(3):351-9
pubmed: 10064565
Mutat Res Rev Mutat Res. 2014 Oct-Dec;762:22-36
pubmed: 25484616
Amino Acids. 2006 Feb;30(1):1-15
pubmed: 16463021
FEBS Lett. 1980 Dec 29;122(2):171-4
pubmed: 6110564
Fundam Appl Toxicol. 1996 Apr;30(2):213-9
pubmed: 8812268
Crit Rev Toxicol. 2019 Nov;49(10):819-929
pubmed: 31944156
Toxicol Appl Pharmacol. 2009 Sep 15;239(3):215-23
pubmed: 19573548
Curr Protoc Toxicol. 2007 Nov;Chapter 6:Unit6.13
pubmed: 23045149
Drug Metab Dispos. 1998 Jan;26(1):12-9
pubmed: 9443846
J Med Chem. 2020 Jun 25;63(12):6315-6386
pubmed: 32182061
Toxicol Appl Pharmacol. 2013 May 1;268(3):343-51
pubmed: 23428393
J Pharmacol Exp Ther. 2006 Feb;316(2):520-9
pubmed: 16269531

Auteurs

R Dekant (R)

Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.

R Bertermann (R)

Department of Inorganic Chemistry, University of Würzburg, Am Hubland, 97074, Würzburg, Germany.

J Serban (J)

Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.

S Sharma (S)

Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.

M Shinohara (M)

Chemicals Company, AGC Inc, CSR Office, 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, 100-8405, Japan.

Y Morizawa (Y)

Chemicals Company, AGC Inc, CSR Office, 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, 100-8405, Japan.

H Okamoto (H)

Chemicals Company, AGC Inc, CSR Office, 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, 100-8405, Japan.

W Brock (W)

Brook Scientific Consulting LLC, Hilton Head Island, SC, USA.

W Dekant (W)

Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.

A Mally (A)

Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany. mally@toxi.uni-wuerzburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH